Efficacy of nafarelin in assisted reproductive technology: a meta-analysis

By Wong J.M.  

Human Reproduction Update, Vol. 7, Iss. 1, 2001-02 ,pp. : 92-101

Oxford University Press

Access to resources Recommend Favorite

Anti-Mllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

By La Marca A.   Sighinolfi G.   Radi D.   Argento C.   Baraldi E.   Artenisio A. Carducci   Stabile G.   Volpe A.  

Human Reproduction Update, Vol. 16, Iss. 2, 2010-10 ,pp. : 113-130

Oxford University Press

Access to resources Recommend Favorite

Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care

By Koning A.M.H.   Kuchenbecker W.K.H.   Groen H.   Hoek A.   Land J.A.   Khan K.S.   Mol B.W.J.  

Human Reproduction Update, Vol. 16, Iss. 3, 2010-11 ,pp. : 246-254

Oxford University Press

Access to resources Recommend Favorite

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review

By van Wely Madelon   Kwan Irene   Burt Anna L.   Thomas Jane   Vail Andy   Van der Veen Fulco   Al-Inany Hesham G.  

Human Reproduction Update, Vol. 18, Iss. 3, 2012-05 ,pp. : 340-340

Oxford University Press

Access to resources Recommend Favorite

The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis

By Vitthala S.   Gelbaya T.A.   Brison D.R.   Fitzgerald C.T.   Nardo L.G.  

Human Reproduction Update, Vol. 15, Iss. 1, 2009-01 ,pp. : 45-55

Oxford University Press

Access to resources Recommend Favorite